Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery

Completed · Not applicable

Conditions studied: Hypoglycemia

In brief

The purpose of this study is to find out the effects of hypoglycemia on cognition in healthy individuals and how well changes in (interstitial) tissue glucose levels correlate with changes in cognitive function as compared to blood glucose levels.

Key facts

Study ID

NCT01283126

Run by

Joslin Diabetes Center

People needed

20

Starts

2011-01-01

Expected to finish

2015-10-01

Last updated by the study team

2017-05-09

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• non obese (BMI <30), ages 18-50

You may not qualify if…

• renal or hepatic failure
• cancer or lymphoma
• malabsorption or malnourishment
• hypercortisolism
• alcoholism or drug abuse
• anemia
• eating disorder or depression
• coronary artery disease
• Arrhythmias
• hypertension
• on medications known to affect the blood glucose to be measured such as
• glucocorticoids
• on blood thinning agents
• Pregnant women, breastfeeding women and women who want to become pregnant in the next 6 months will be excluded from the study.
• Subjects who have donated blood two weeks prior to the study.
• Allergies to pig derived products (Heparin will be used)

Where it is running

• Joslin Diabetes Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.